We identified one uncontrolled clinical trial, Kwon et al. [29], describing the efficacy of ACE inhibitors (enalapril) or β-blockers (carvedilol) in 23 Korean patients (22 with DMD and one with BMD; mean age: 13 years, range not reported). This evidence concerns the gene ACE and Duchenne muscular dystrophy.